Search Results
Site Search
Thanksgiving Specimen Shipping Guidelines and Schedule - Insights
Due to the Thanksgiving holiday (recognized on Thursday, Nov. 28), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure specimen stability and prevent delays, follow the guidelines outlined below for...
Independence Day Specimen Shipping Guidelines and Schedule - Insights
Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered due to the upcoming July 4th holiday. To ensure specimen stability and prevent delays, follow the guidelines outlined below for domestic clients and...
Understanding a Broken Heart: Genetic Testing After Sudden Cardiac Death - Insights
PACE/State of FL - Presentation Recording Coming Soon - Sudden cardiac death (SCD) is a devastating event that occurs unexpectedly, often without any prior symptoms. This webinar will discuss how postmortem genetic testing may be used in...
The Quality Auditor Role - Assessing the Laboratory - Insights
PACE/State of FL - Internal assessments are integral to a laboratory’s quality management system (QMS).
Psychotropic PGx Panel for Drug Treatment Optimization [Test in Focus] - Insights
Ann Moyer, M.D., Ph.D. gives an overview of this new test available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing improves upon other testing approaches, and what clinical action can...
Sickle cell disease: How new technologies are transforming patient lives - Insights
PACE/State of FL - The current knowledge regarding sickle cell disease from its genetic cause to the myriads of effects it can have for affected individuals.
Standard Operating Procedures (SOPs): The 5 W's and How - Insights
PACE/State of FL - The who, what, why, where, when and how of well written effective procedures that can: help to improve the quality of work within the organization, help reduce the number of errors and omissions, and help new people...
Autopsy Lab - Lean Transformation - Insights
PACE/State of FL - An in-depth look at the efforts to improve the efficiency and effectiveness of the Autopsy Lab through Lean principles.
Lab Billing, Coding, and Compliance: A 2025 Overview - Insights
PACE/State of FL - Critical topics essential for laboratory billing, coding, and compliance.
Optimizing Cancer Care: ASCO Guidelines for Germline Genetic Testing - Insights
PACE/State of FL - The latest ASCO guidelines for selection of germline genetic testing panels for cancer patients.
Metagenomic Sequencing - A Tool for Diagnosis of Central Nervous System Infection - Insights
PACE/State of FL - Metagenomic sequencing for diagnosing central nervous system infection. Content will be shared regarding technical details, clinical applications, and results interpretation, drawing on both current literature and...
T-cell Lymphoma [Test in Focus] - Insights
Andrew Feldman, M.D., discusses the different tools and techniques Mayo Clinic Laboratories uses to accurately diagnose and classify T-cell lymphomas to help provide clinicians with the diagnostic answers they need to treat their patients.
Mayo Clinic Laboratory and Pathology Research Roundup: Nov. 20 - Insights
This week’s Research Roundup highlights prehospital transfusion for gastrointestinal bleeding.
Test panel guides diagnosis of early onset IBD: Ann Moyer, M.D., Ph.D. - Insights
Ann Moyer, M.D., Ph.D., explains how Mayo Clinic Laboratories' test panel provides comprehensive evaluation of patients with suspected monogenic early onset inflammatory bowel disease, or IBD. Accurate diagnosis is key to guiding therapy...
Paul Jannetto, Ph.D., explains the advantages that Mayo Clinic Laboratories' oral fluid drug screening offers over typical urine tests. Oral samples are easier to collect and harder to adulterate.
Learn how our melanoma testing identifies variants in 17 genes associated with diagnosis, prognosis, and treatment guidance.
Mayo Clinic Laboratory and Pathology Research Roundup: May 14 - Insights
This week's research roundup feature: Despite advances in understanding the genetic abnormalities in myeloproliferative neoplasms (MPNs) and the development of JAK2 inhibitors, there is an urgent need to devise new treatment strategies,...
Chromosomal microarray - Insights
Learn how our microarray evaluations identify, analyze, and assess clinically significant chromosomal abnormalities.
Hereditary epilepsy - Insights
Find out how we perform in-depth mutation and copy number variant analysis to determine causes of epilepsy and identify potential treatment options.
Mayo Clinic Laboratory and Pathology Research Roundup: April 16 - Insights
This week's research roundup feature: R0 resection and radiation therapy have been associated with improved overall survival (OS) in patients with thymic carcinoma (TC). Here, we analyzed which subgroups of patients derive the greatest...
FDA Regulation of Laboratory Developed Tests - Insights
PACE/State of FL - A brief history of the FDA’s interest in LDTs and detailing new requirements.
Mayo Clinic Laboratory and Pathology Research Roundup: Aug. 7 - Insights
This week’s Research Roundup highlights a randomized controlled trial of postoperative belladonna and opium rectal suppositories in vaginal surgery.
Assay stratifies pregnant women's preeclampsia risk: Joshua Bornhorst, Ph.D. - Insights
Joshua Bornhorst, Ph.D., explains how Mayo Clinic Laboratories' unique assay identifies pregnant women at risk of developing preeclampsia with severe features. Test results can guide clinical management, to safeguard maternal and neonatal...
Mayo Clinic Laboratory and Pathology Research Roundup: May 28 - Insights
This week’s Research Roundup highlights the clinical and pathology findings associated consistently with larger glomerular volume.
Mayo Clinic Laboratory and Pathology Research Roundup: June 12 - Insights
This week’s Research Roundup highlights noninvasive assessment of renal fibrosis with magnetization transfer MR imaging.
Diagnostic and companion testing - Insights
Learn more about how diagnostic and companion testing can confirm a prenatal genetic diagnosis.
August 2023 - Hematopathology - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Hematopathology.
What You Should Know about Rocky Mountain Spotted Fever - Insights
A Wisconsin woman has died of Rocky Mountain spotted fever in what Wisconsin health officials have confirmed is the first documented death from the infection in the state. Bobbi Pritt, M.D., Director of the Clinical Parasitology Laboratory...
Mayo Clinic Laboratory and Pathology Research Roundup: February 13 - Insights
This week's research roundup feature: VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome, caused by somatic mutations in UBA1, is an autoinflammatory disorder with diverse systemic manifestations. Thrombosis is a...
Mayo Clinic Laboratory and Pathology Research Roundup: February 27 - Insights
This week's research roundup feature: Both targeted therapies and immunotherapies provide benefit in resected Stage III melanoma. We hypothesized that the combination of targeted and immunotherapy given prior to therapeutic lymph node...
Week in Review: April 29 - Insights
Today's highlights include: CDC estimates 3 in 4 kids have had coronavirus infections, virtual in-person cardiac rehabilitation provide similar benefits, and Mayo Clinic partners with AI startup to co-develop precision medicine.
Week in Review: May 6 - Insights
Today's highlights include: Mental health needs rise as pandemic fluctuates, an algorithm that analyzes apple watch data shows early promise in detecting heart problems, and Minnesota physicians brace for Roe v. Wade decision
November 2023 - Gynecological Pathology / Laboratory Genetics and Genomics - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case’s sub-specialties are Gynecological Pathology and Laboratory Genetics and Genomics.
Mayo Clinic Laboratory and Pathology Research Roundup: March 11 - Insights
This week’s Research Roundup highlights an assay to rapidly screen for immunoglobulin light chain glycosylation: a potential path to earlier AL diagnosis for a subset of patients and several other research articles by Mayo Clinic physicians...
COVID-19 weekly news: March 7-11 2022 - Insights
Topic's Include: Losing sleep during the pandemic? It may be affecting your weight, heart, and overall health, and how to deal with anxiety, stress when the world feels overwhelming.
Mayo Clinic Laboratory and Pathology Research Roundup: March 13 - Insights
This week’s Research Roundup highlights the clinical and pathological evolution of giant cell arteritis with a prospective study of follow-up temporal artery biopsies in 40 treated patients.
PACE/State of FL - Register now – Sept. 10, 2025
Tissue testing for COVID-19 - Insights
Being able to identify SARS-CoV-2 in tissue is key to better understand the virus that causes COVID-19. Now, a first-of-its-kind test that detects SARS-CoV-2 in formalin-fixed, paraffin-embedded tissue is available from Mayo Clinic...
Nonalcoholic Steatohepatitis (NASH)-FibroTest* [Test in Focus] - Insights
Nikola Baumann, Ph.D., gives an overview of the new NASH-FibroTest available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing improves upon previous testing approaches, and what clinical...
New tests launched in November - Insights
In November 2022, Mayo Clinic Laboratories announced eighteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Updated testing algorithms for plasma cell proliferative disorders [Test in Focus] - Insights
Xinjie Xu, Ph.D., co-director of Mayo's Genetics and Genomics Laboratory, explains Mayo Clinic Laboratories' updated approach to testing for risk stratification of patients newly diagnosed with plasma cell proliferative disorders, such as...
Mayo Clinic Laboratories easily consumable content, ensuring knowledge retention in minimal time. These microlearning educational offerings will cover a variety of topics relevant to current and aspiring laboratory leaders.
Dr. Dong Chen and Dr. Sounak Gupta joined the “Becker’s Healthcare Podcast” to discuss the molecular testing space and its important role in personalized cancer treatment. Dr. Chen and Dr. Gupta highlighted the importance of selecting the...
Severe storms affecting FedEx hub in Memphis, TN - Insights
Due to severe weather affecting the FedEx hub in Memphis, Tennessee, delays are anticipated. The Mayo Clinic Laboratories’ Global Logistics team will be diverting work to other commercial shipping options.
Dr. Morice discusses lab market trends with the Advisory Board - Insights
William Morice II, M.D., Ph.D., recently joined the Advisory Board for a webinar discussion on 2024 lab market trends. Dr. Morice covered the current lab market outlook, the priority trends, and opportunities for future growth.
Mayo Clinic Laboratories, a leading global reference laboratory, and Progentec Diagnostics, a digital health and biomarker technology-based company focused on autoimmune conditions, today announced a strategic collaboration to bring...
What's New in Quality and Regulatory? [2023] - Insights
PACE/State of FL - An overview of the most common CLIA deficiencies in 2022 and ideas for avoiding noncompliance. The presenters will also review new CMS rules for remote review that were published at the end of the COVID-19 public health...
Leveraging Lessons from the Past - Insights
Sharing lessons learned from past process improvement and other projects conducted at Mayo Clinic.
Mayo Clinic Laboratories' algorithmic approach to vector-borne disease testing supports the selection of the right test for the right region. Our full suite of vector-borne disease tests includes expert-developed assays for the most...
Assay monitors response to monoclonal antibody therapy: Maria Alice Willrich, Ph.D. - Insights
Maria Alice Willrich, Ph.D., explains how Mayo Clinic Laboratories' new assay provides therapeutic drug monitoring of risankizumab, or RISA. Test results help guide care for patients with plaque psoriasis, psoriatic arthritis, and Crohn's...